FDA OKs trial of pig livers as dialysis-like treatment for liver failure
U.S. researchers will soon test whether livers from a gene-edited pig could treat people with sudden liver failure — by temporarily filtering their blood so their own organ can rest and maybe heal.
The first-of-its-kind clinical trial has been cleared by the Food and Drug Administration, according to pig producer eGenesis, which announced the step Tuesday with its partner OrganOx.
An estimated 35,000 people in the U.S. are hospitalized each year when their liver suddenly fails. There are few treatment options and death rates as high as 50%. Many don't qualify for a liver transplant or can't get a match in time.
The new study, which is expected to get underway later this spring, is a twist on the quest for animal-to-human organ transplants. Researchers won't transplant the pig liver but instead will attach it externally to study participants.
The liver is the only organ that can regenerate, but the question is whether having the pig's liver filter the patient's blood for several days could give it that chance.
In experiments with four deceased bodies, that 'bridge' attempt showed the pig liver could support some functions of a human liver for two or three days, said Mike Curtis, CEO of Massachusetts-based eGenesis, which genetically modifies pigs so their organs are more humanlike.
The trial will enroll up to 20 patients in intensive-care units who don't qualify a liver transplant, he said. A device made by Britain's OrganOx, currently used to preserve donated human livers, will pump participants' blood through the pig liver.
It's the latest step in attempts to use gene-edited pig organs to save human lives. Pig kidneys from eGenesis and another pig producer, United Therapeutics, are being used in experimental transplants.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scotsman
5 hours ago
- Scotsman
Over 1,000 yogis set to downward dog at Emirates Arena for largest event of its kind
In just one week over 1,000 yoga enthusiasts will be namaste-ing at the Emirates Arena in Glasgow as part of a World Yoga Day event with renowned PYPT practitioner, Sadhvi Devaditi. Sign up to our daily newsletter – Regular news stories and round-ups from around Scotland direct to your inbox Sign up Thank you for signing up! Did you know with a Digital Subscription to The Scotsman, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more. Learn More Sorry, there seem to be some issues. Please try again later. Submitting... Tickets for the event – believed to be the biggest of its kind - are being snapped up quickly with over 900 already reserved, and organisers are encouraging others to secure their spot now and join the movement. The clincher, tickets are completely free. This year's event promises to be the biggest and most dynamic yet, with a live international broadcast from the Emirates Arena. Advertisement Hide Ad Advertisement Hide Ad The event is a major part of Scotland's contribution to World Yoga Day, recognised globally on 21 June. Sunita Poddar, Chairperson of the Patanjali Yog Peeth (Scotland) Trust In the lead-up to the big day, the city is embracing yoga like never before. Free yoga classes will be offered to offices, schools, and community groups across Glasgow and Edinburgh from 16 to 23 June, helping people of all backgrounds experience the physical and mental health benefits of yoga. This special event is hosted by the Consulate General of India, Edinburgh, and Patanjali Yog Peeth (UK) Trust, with support from Glasgow Indians Association The events are designed to introduce people to yoga, celebrate the community spirit of new and experienced yogis across Glasgow, and supports the bringing together of from across Glasgow to celebrate the benefit of yoga. Advertisement Hide Ad Advertisement Hide Ad Sunita Poddar, Chairperson of the Patanjali Yog Peeth (Scotland) Trust, said: 'Yoga is for everyone - it transcends age, background, and ability. 'At PYPT, we are committed to promoting holistic health and wellbeing by reconnecting communities with the ancient wisdom of yoga. Our aim is to inspire positive change, both physically and mentally, and empower individuals to take control of their own wellbeing. 'This celebration at the Emirates Arena is a chance to come together and experience the transformative power of yoga - we welcome everyone to be part of this special day.' Sunita Poddar is the founder and chief executive of Glasgow-based care home group, Oakminster Healthcare. Part of her mission to root her businesses and approach to person-centred resident care in health and wellbeing will see the team of care home wellbeing enablers trained to deliver low-impact yoga sessions for residents across the five care homes in Govan, Kinning Park, Pollokshields, St George's Cross and Knightswood. The PYPT Yoga Event is free, but registration is essential via Eventbrite.
Scotsman
9 hours ago
- Scotsman
Biofilm prevention leader Remora announces groundbreaking partnership with global textile chemical innovator
Award-winning Scottish biotechnology company Remora has announced a major milestone in its commercial journey after signing a new long-term licensing agreement with Swiss-based Beyond Surface Technologies (BST) to bring its revolutionary biofilm prevention technology to the global textile market. Sign up to our daily newsletter – Regular news stories and round-ups from around Scotland direct to your inbox Sign up Thank you for signing up! Did you know with a Digital Subscription to The Scotsman, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more. Learn More Sorry, there seem to be some issues. Please try again later. Submitting... Award-winning Scottish biotechnology company Remora has announced a major milestone in its commercial journey after signing a new long-term licensing agreement with Swiss-based Beyond Surface Technologies (BST) to bring its revolutionary biofilm prevention technology to the global textile market. The partnership will see BST – a specialist in sustainable textile chemistry – integrate the patented Remora® technology into its green chemical formulations for use across performance apparel, outdoor garments and technical fabrics. Advertisement Hide Ad Advertisement Hide Ad Biofilms – invisible layers of microorganisms that adhere to fabrics – are a widespread issue in the textile sector. On performance garments in particular, they cause persistent odours, staining, and material degradation, even after repeated washing. They also pose risks of skin irritation and contamination. Matthias Foessel, Co-founder and CEO of Beyond Surface Technologies Remora® technology offers a breakthrough solution. Developed using a scientifically engineered molecule inspired by red seaweed's natural defense mechanisms, it prevents biofilm formation at source, without relying on toxic antimicrobial agents. Remora's collaboration with BST will support the sustainable creation of cleaner, fresher and longer-lasting textiles. The technology can be used at multiple stages of the supply chain. Dr Yvonne Davies, Chief Commercial Officer at Remora, said: 'This partnership with BST is a transformational step for Remora and a breakthrough moment for the textile industry. Our Remora® technology offers a sustainable, scientifically proven alternative to toxic biocidal treatments and will help brands tackle persistent odour, staining and material degradation caused by biofilms. 'Through BST's extensive global supply chain relationships and deep expertise in green chemistry, we now have a clear route to market with some of the biggest names in fashion, performance wear and technical textiles. This collaboration doesn't just scale our technology, it unlocks its full potential to support a cleaner, safer and more sustainable future for textiles.' Advertisement Hide Ad Advertisement Hide Ad Matthias Foessel, Co-founder and CEO of Beyond Surface Technologies, said: 'We are excited to bring this remarkable marine-inspired technology for biofilm prevention to the textile industry. It offers a unique way to keep fabrics and garments cleaner and fresher for longer. 'We're very pleased to have signed this collaboration with Remora, based on a Unilever patent portfolio. This partnership marks another important milestone in our mission to advance chemistry with reduced environmental impact - without compromising on performance.' Originally developed through a decade-long R&D collaboration with Unilever and leading UK universities, Remora's technology now has a direct route into commercial textile markets via BST's formulation expertise and global customer network – which includes many of the world's best-known fashion and sportswear brands.
Press and Journal
21 hours ago
- Press and Journal
Nappies cut ruled out as London-based experts drafted in to help NHS Grampian save millions
Health bosses have voted against plans to slash spending on newborn tots amid fears scrapping hospital nappies 'would do more harm than good'. A shock dossier earlier this week revealed a range of services across the north-east could be axed or reduced to save the health board £23 million. This included halting cancer treatment and elective surgeries on public holidays and even stopping giving out disposable nappies for most newborn babies. The proposed cost-cutting measures would have impacted expectant mums at maternity wards in Aberdeen, Inverurie, Peterhead and Elgin. It comes as NHS Grampian bosses scramble to recoup millions of pounds after officially becoming the most broke health board in Scotland. They currently have a staggering £68m overspend that they aim to reduce to £45m in the next 12 months. And now, external experts have been drafted in to help them balance the books. Government officials haven hired London-based advisors KPMG to crunch the numbers and help NHS Grampian come up with an expansive savings plan. They say the cash crisis within the health board has escalated to the point where there is a need for experts to intervene amid concerns over failing to improve services. Adam Coldwells reassured board members that NHS Grampian will still be 'absolutely in charge' of the recovery plan and the changes they implement further down the line. However, the external body will be there to monitor their progress, give advice on possible additional savings the board might have missed and 'hold them to account'. The interim chief executive said this is a necessary measure to turn the health board's fortunes around as 'the scale of the [financial] challenge is significant'. And he stressed this would be a good opportunity to learn and improve. He added: 'Clearly it's an extremely serious issue and relates primarily to our financial position, which as a board we've been working on for the last two years. 'We've certainly struggled to find the scale of savings that we need to. 'I'm optimistic this external support from an organisation, who has done this lots of times, will be able to find things that we've simply not been able to identify ourselves.' Members of the NHS Grampian board were later presented with a detailed report outlining 79 cost-cutting measures which will be implemented within the next year. Health bosses admit about a dozen of those could have direct impact on vulnerable patients – with a range of medical services no longer taking place on public holidays. This would affect non-emergency surgeries and diagnostic tests, as well as cancer treatments such as chemotherapy and radiation therapy. Routine test results will also be given by phone or letter, with face-to-face appointments taking place only when essential. The aim is to cut down on overtime pay. Board member Derick Murray questioned whether they are not 'taking a step back' by reducing these services. But interim director of people and culture, Philip Shipman, said running services on public holidays is 'incredibly expensive' so that's a good place to make a saving. Dr Colette Backwell later also reminded fellow board members that the recovery plan they have been presented with is a necessity rather than a choice. 'The Scottish Government is asking us to find more savings so we have to go along with that,' she said. Staff at pharmacies will also be taking a day off on public holidays from now on. Members raised concerns this could result in people not getting the treatment they need in a timely manner or being missed altogether. Area clinical forum chairman Mark Burrell admitted other health committees have had similar worries too. However, he reassured that there is a 'robust evaluation' under way so that 'patients do not suffer' at the hands of the proposed changes. 'This is kept under very close review,' Mr Burrell added. One of the proposed measures was, however, scratched from the plans amid fears it 'would not be supportive of vulnerable parents'. Board chairwoman Alison Evison raised concerns that if they stop giving out nappies at hospitals, parents might end up without any supplies at an already stressful time. This option would have essentially saved them around £8,000 per year. But Mrs Evison didn't think 'such a small' amount would justify the impact of going ahead with the proposals. She said: 'This saving has huge implications for certain people who are in need of that kind of support when they're coming to hospital. 'And yet, the saving associated with it is actually relatively small. 'Sometimes people will be coming to a hospital to have a baby when they are not expecting it at that point in time. It's a case of just not being prepared. 'So I think we are actually trying to make a saving which is going to be more negative than supportive.' All of the other proposals were given the green light, however, with a more detailed report being presented to the board in October.
